OTCMKTS:BIOTU

Biotech Acquisition Competitors

$10.06
+0.06 (+0.60 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.01
Now: $10.06
$10.08
50-Day Range
$9.89
MA: $10.16
$10.70
52-Week Range
$9.79
Now: $10.06
$10.95
Volume30,559 shs
Average Volume119,772 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Biotech Acquisition (OTCMKTS:BIOTU) Vs. SCCB, ACEVU, ACKIU, ADRAU, ADEXU, and IMPXU

Should you be buying BIOTU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to Biotech Acquisition, including 378 (SCCB), ACE Convergence Acquisition (ACEVU), Ackrell SPAC Partners I (ACKIU), Adara Acquisition (ADRAU), Adit EdTech Acquisition (ADEXU), and AEA-Bridges Impact (IMPXU).

378 (OTCMKTS:SCCB) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for 378 and Biotech Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
3780000N/A
Biotech Acquisition0000N/A

Profitability

This table compares 378 and Biotech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
378N/AN/AN/A
Biotech AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares 378 and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
378N/AN/AN/AN/AN/A
Biotech AcquisitionN/AN/AN/AN/AN/A

ACE Convergence Acquisition (OTCMKTS:ACEVU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for ACE Convergence Acquisition and Biotech Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ACE Convergence Acquisition0000N/A
Biotech Acquisition0000N/A

Profitability

This table compares ACE Convergence Acquisition and Biotech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ACE Convergence AcquisitionN/AN/AN/A
Biotech AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares ACE Convergence Acquisition and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ACE Convergence AcquisitionN/AN/AN/AN/AN/A
Biotech AcquisitionN/AN/AN/AN/AN/A

Ackrell SPAC Partners I (OTCMKTS:ACKIU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for Ackrell SPAC Partners I and Biotech Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ackrell SPAC Partners I0000N/A
Biotech Acquisition0000N/A

Profitability

This table compares Ackrell SPAC Partners I and Biotech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ackrell SPAC Partners IN/AN/AN/A
Biotech AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares Ackrell SPAC Partners I and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ackrell SPAC Partners IN/AN/AN/AN/AN/A
Biotech AcquisitionN/AN/AN/AN/AN/A

Adara Acquisition (OTCMKTS:ADRAU) and Biotech Acquisition (OTCMKTS:BIOTU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of current ratings for Adara Acquisition and Biotech Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Adara Acquisition0000N/A
Biotech Acquisition0000N/A

Valuation & Earnings

This table compares Adara Acquisition and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adara AcquisitionN/AN/AN/AN/AN/A
Biotech AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Adara Acquisition and Biotech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Adara AcquisitionN/AN/AN/A
Biotech AcquisitionN/AN/AN/A

Biotech Acquisition (OTCMKTS:BIOTU) and Adit EdTech Acquisition (OTCMKTS:ADEXU) are both -- companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Biotech Acquisition and Adit EdTech Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Biotech Acquisition0000N/A
Adit EdTech Acquisition0000N/A

Earnings & Valuation

This table compares Biotech Acquisition and Adit EdTech Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biotech AcquisitionN/AN/AN/AN/AN/A
Adit EdTech AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Biotech Acquisition and Adit EdTech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Biotech AcquisitionN/AN/AN/A
Adit EdTech AcquisitionN/AN/AN/A

Biotech Acquisition (OTCMKTS:BIOTU) and AEA-Bridges Impact (OTCMKTS:IMPXU) are both -- companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Biotech Acquisition and AEA-Bridges Impact, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Biotech Acquisition0000N/A
AEA-Bridges Impact0000N/A

Earnings & Valuation

This table compares Biotech Acquisition and AEA-Bridges Impact's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biotech AcquisitionN/AN/AN/AN/AN/A
AEA-Bridges ImpactN/AN/AN/AN/AN/A

Profitability

This table compares Biotech Acquisition and AEA-Bridges Impact's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Biotech AcquisitionN/AN/AN/A
AEA-Bridges ImpactN/AN/AN/A


Biotech Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
378 logo
SCCB
378
0.5$25.60+0.5%$0.00N/A0.00
ACEVU
ACE Convergence Acquisition
0.0$10.95+0.3%$0.00N/A0.00News Coverage
ACKIU
Ackrell SPAC Partners I
0.0$10.21+0.4%$0.00N/A0.00
ADRAU
Adara Acquisition
0.0$9.97+0.3%$0.00N/A0.00High Trading Volume
ADEXU
Adit EdTech Acquisition
0.0$9.99+0.0%$0.00N/A0.00High Trading Volume
IMPXU
AEA-Bridges Impact
0.0$10.55+1.1%$0.00N/A0.00High Trading Volume
ARBGU
Aequi Acquisition
0.0$10.16+0.1%$0.00N/A0.00
AFAQU
AF Acquisition Corp. Units
0.0$10.00+0.4%$0.00N/A0.00News Coverage
African Gold Acquisition logo
AGACU
African Gold Acquisition
0.0$9.99+0.0%$0.00N/A0.00High Trading Volume
Quiet Period Expiration
ATAQU
Altimar Acquisition Corp. III
0.0$10.12+0.6%$0.00N/A0.00High Trading Volume
Quiet Period Expiration
AGCUU
Altimeter Growth
0.0$14.62+1.7%$0.00N/A0.00
ANZUU
Anzu Special Acquisition Corp I Units
0.0$10.08+0.4%$0.00N/A0.00Quiet Period Expiration
ATSPU
Archimedes Tech SPAC Partners Co. Unit
0.0$9.95+0.2%$0.00N/A0.00
ACTCU
ArcLight Clean Transition
0.0$20.94+6.1%$0.00N/A0.00Gap Up
ARKIU
Ark Global Acquisition Corp. Unit
0.0$10.02+0.8%$0.00N/A0.00
ARRWU
Arrowroot Acquisition Corp. Unit
0.0$10.02+0.3%$0.00N/A0.00Quiet Period Expiration
SWETU
Athlon Acquisition
0.0$10.06+0.6%$0.00N/A0.00
ACICU
Atlas Crest Investment
0.0$10.81+1.3%$0.00N/A0.00High Trading Volume
News Coverage
AUUD
Auddia
0.0$3.05+0.0%$0.00N/A0.00News Coverage
AEACU
Authentic Equity Acquisition
0.0$10.15+0.4%$0.00N/A0.00
AVANU
Avanti Acquisition
0.0$10.69+0.0%$0.00N/A0.00High Trading Volume
BRPMU
B. Riley Principal 150 Merger
0.0$10.05+0.2%$0.00N/A0.00
BCYPU
Big Cypress Acquisition
0.0N/AN/A$0.00N/A0.00
BGFPX
Blackstone / GSO Floating Rate Enhanced Income Fund
0.5N/AN/A$0.00N/A0.00High Trading Volume
BGFVX
Blackstone / GSO Floating Rate Enhanced Income Fund
0.5$25.11+0.1%$0.00N/A0.00High Trading Volume
BOACU
Bluescape Opportunities Acquisition
0.0$10.75+0.7%$0.00N/A0.00High Trading Volume
BREZU
Breeze Holdings Acquisition
0.0$10.62+2.4%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0N/AN/A$0.00N/A0.00News Coverage
BTAQU
Burgundy Technology Acquisition
0.0$10.59+1.5%$0.00N/A0.00
CAHCU
CA Healthcare Acquisition
0.0$10.43+0.4%$0.00N/A0.00
CNBTF
Cannara Biotech
0.5$0.14+14.3%$0.00N/A0.00
CTAQU
Carney Technology Acquisition Corp. II
0.0$10.06+0.9%$0.00N/A0.00
GLBLU
Cartesian Growth
0.0$9.98+0.1%$0.00N/A0.00Quiet Period Expiration
CBAHU
CBRE Acquisition
0.0$10.25+0.4%$0.00N/A0.00High Trading Volume
CENHU
Centricus Acquisition
0.0$10.04+0.6%$0.00N/A0.00
CFVIU
CF Acquisition Corp. VI
0.0$10.00+0.1%$0.00N/A0.00
CLRMU
Clarim Acquisition
0.0$10.03+0.4%$0.00N/A0.00
CLIMU
Climate Real Impact Solutions II Acquisition
0.0$10.35+0.7%$0.00N/A0.00High Trading Volume
News Coverage
CMIIU
CM Life Sciences II
0.0$12.98+0.5%$0.00N/A0.00Quiet Period Expiration
CMLTU
CM Life Sciences III Inc. Unit
0.0$11.20+0.4%$0.00N/A0.00
CMLFU
CM Life Sciences
1.0$16.58+5.2%$0.00N/A0.00Gap Down
COLIU
Colicity
0.0$10.21+0.1%$0.00N/A0.00Quiet Period Expiration
CLAAU
Colonnade Acquisition Corp. II
0.0$9.96+0.2%$0.00N/A0.00High Trading Volume
CHFWU
Consonance-HFW Acquisition
0.0$10.38+0.0%$0.00N/A0.00High Trading Volume
CONXU
CONX
0.0$10.35+0.6%$0.00N/A0.00
CRZNU
Corazon Capital V838 Monoceros
0.0$10.01+0.1%$0.00N/A0.00High Trading Volume
COVAU
COVA Acquisition
0.0$10.03+0.3%$0.00N/A0.00
CPTKU
Crown PropTech Acquisitions
0.0$10.00+0.2%$0.00N/A0.00High Trading Volume
DCRNU
Decarbonization Plus Acquisition Co. II
0.0$10.31+0.4%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$10.08+0.2%$0.00N/A0.00
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.